A judge has raised concerns about the utility of referring a satellite dispute over whistleblower protections to the Full Court in a $13 million lawsuit brought by an ex-Greenwoods & Herbert Smith Freehills partner.
Jimās Group has paid a $24,420 fine after the Australian Competition and Consumer Commission accused the company of breaching the Franchise Code and misleading a franchisee.
US-based multinational firm Jones Day has lured a partner from Clayton Utz to join its intellectual property team in Melbourne.
A judge has ordered a Victoria local councillor to pay a developer $205,000 in damages after finding he was responsible for comments on a community Facebook page he ran that alleged the developer was corrupt.
The self-declared āwolf traderā of the Gold Coast, Tyson Scholz, has won his bid to exclude ASICās evidence about the meaning of his tweets in its case accusing him of providing unlicensed financial services.
Liquidators have been appointed to a litigation funder behind a funding agreement ripped up by the court last year that would have given it a hefty 85 per cent commission.
Fintech Humm has admitted to making āmisrepresentationsā to Japanese bank SMBC over allegedly worthless receivables linked to Forum Finance but has denied it was negligent, claiming a Forum Group unit should share the burden of paying any damages in the $33.6 million lawsuit.
Responding to increasing crackdowns on anti-money laundering and counter terrorism breaches, Melbourne consulting firm KordaMentha has merged with Australian advisory firm Murray Waldren Consulting to form a new financial crimes service. The partnership comes off the back of damning reports by gaming regulators in NSW and Victoria into major casinos Star Entertainment and Crown Resorts.…
For many in the legal profession the choice of Justice Jayne Jagot to replace the outgoing Justice Patrick Keane on the High Court, heralding a new era of judicial diversity on the top bench, was hardly a surprise.
A judge has thrown out competing appeals of a decision finding Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.